The Management of Hypertension in the Overweight and Obese Patient: Is Weight Reduction Sufficient?

By Jacob S.  

Drugs, Vol. 64, Iss. 11, 2004-01 ,pp. : 1263-1263

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly Obese: The `Critical Weight' and the `Fictitious Height', a Possible Solution to an Unsolved Problem?

By Colla L. La  

Clinical Pharmacokinetics, Vol. 48, Iss. 6, 2009-06 ,pp. : 397-398

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Orlistat in a 1-Year Weight-Management Programme for Treating Overweight and Obese Patients in Sweden: A Treatment Responder Approach

By Hertzman Peter  

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1007-1020

Adis International

Access to resources Recommend Favorite

Bevacizumab and hypertension: a Catch-22?

By  

Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Gene therapy for pulmonary hypertension?

By  

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite